Pfizer Inc and BioNTech SE announced that the U.S. Food and Drug Administration has authorized for emergency use the Pfizer-BioNTech COVID-19 Vaccine for children 5 through 11 years of age (also referred to as 5 to <12 years). For this age group, the vaccine is to be administered in a two-dose regimen of 10-µg doses given 21 days apart. The 10-µg dose level was carefully selected based on safety, tolerability and immunogenicity data. This is the first COVID-19 vaccine authorized in the U.S. for individuals 5 through 11 years of age.
- Read more about Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine in Children Ages 5-11 Years
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/pfizer-and-biontech-receive-first-usfda-emergency-use-authorization-of-a-covid-19-vaccine-in-children-ages-5-11-years
No comments:
Post a Comment